JPH0730035B2 - Process for producing pyridazinone compound - Google Patents
Process for producing pyridazinone compoundInfo
- Publication number
- JPH0730035B2 JPH0730035B2 JP2147087A JP14708790A JPH0730035B2 JP H0730035 B2 JPH0730035 B2 JP H0730035B2 JP 2147087 A JP2147087 A JP 2147087A JP 14708790 A JP14708790 A JP 14708790A JP H0730035 B2 JPH0730035 B2 JP H0730035B2
- Authority
- JP
- Japan
- Prior art keywords
- acid
- sulfoxide
- melting point
- chlorophenyl
- pyridazin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- -1 pyridazinone compound Chemical class 0.000 title claims description 35
- 238000000034 method Methods 0.000 title claims description 19
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 18
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N dimethyl sulfoxide Natural products CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 18
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims description 16
- 239000002253 acid Substances 0.000 claims description 14
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 claims description 12
- 125000000217 alkyl group Chemical group 0.000 claims description 11
- 150000001875 compounds Chemical class 0.000 claims description 10
- 125000003118 aryl group Chemical group 0.000 claims description 7
- 229940098779 methanesulfonic acid Drugs 0.000 claims description 7
- 229910052739 hydrogen Inorganic materials 0.000 claims description 6
- 239000001257 hydrogen Substances 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 claims description 5
- 125000005236 alkanoylamino group Chemical group 0.000 claims description 5
- 125000003545 alkoxy group Chemical group 0.000 claims description 5
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 5
- 229910052736 halogen Inorganic materials 0.000 claims description 5
- 150000002367 halogens Chemical class 0.000 claims description 5
- 125000001072 heteroaryl group Chemical group 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 5
- MJWNJEJCQHNDNM-UHFFFAOYSA-N 1-methyl-4-(4-methylphenyl)sulfinylbenzene Chemical compound C1=CC(C)=CC=C1S(=O)C1=CC=C(C)C=C1 MJWNJEJCQHNDNM-UHFFFAOYSA-N 0.000 claims description 4
- JJHHIJFTHRNPIK-UHFFFAOYSA-N Diphenyl sulfoxide Chemical compound C=1C=CC=CC=1S(=O)C1=CC=CC=C1 JJHHIJFTHRNPIK-UHFFFAOYSA-N 0.000 claims description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 4
- HTMQZWFSTJVJEQ-UHFFFAOYSA-N benzylsulfinylmethylbenzene Chemical compound C=1C=CC=CC=1CS(=O)CC1=CC=CC=C1 HTMQZWFSTJVJEQ-UHFFFAOYSA-N 0.000 claims description 4
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 4
- MZMJHXFYLRTLQX-UHFFFAOYSA-N ethenylsulfinylbenzene Chemical compound C=CS(=O)C1=CC=CC=C1 MZMJHXFYLRTLQX-UHFFFAOYSA-N 0.000 claims description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 4
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 4
- 150000003462 sulfoxides Chemical class 0.000 claims description 4
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims description 4
- 125000002252 acyl group Chemical group 0.000 claims description 3
- 125000004423 acyloxy group Chemical group 0.000 claims description 3
- 125000005041 acyloxyalkyl group Chemical group 0.000 claims description 3
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 3
- 125000001188 haloalkyl group Chemical group 0.000 claims description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 3
- JXTGICXCHWMCPM-UHFFFAOYSA-N (methylsulfinyl)benzene Chemical compound CS(=O)C1=CC=CC=C1 JXTGICXCHWMCPM-UHFFFAOYSA-N 0.000 claims description 2
- XVHZFBOFVTZDHG-UHFFFAOYSA-N 2-tert-butyl-5-chloro-1,2-thiazol-3-one Chemical compound CC(C)(C)N1SC(Cl)=CC1=O XVHZFBOFVTZDHG-UHFFFAOYSA-N 0.000 claims description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 2
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical group C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 claims description 2
- 150000007933 aliphatic carboxylic acids Chemical class 0.000 claims description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 2
- 235000019253 formic acid Nutrition 0.000 claims description 2
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 claims description 2
- 229940071870 hydroiodic acid Drugs 0.000 claims description 2
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims description 2
- 229910052760 oxygen Inorganic materials 0.000 claims description 2
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 claims description 2
- 229910052717 sulfur Inorganic materials 0.000 claims description 2
- ITMCEJHCFYSIIV-UHFFFAOYSA-N triflic acid Chemical compound OS(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-N 0.000 claims description 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 3
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical group [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 claims 2
- 125000001424 substituent group Chemical group 0.000 claims 1
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 42
- 238000002844 melting Methods 0.000 description 37
- 230000008018 melting Effects 0.000 description 37
- 239000013078 crystal Substances 0.000 description 19
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 15
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 12
- AAILEWXSEQLMNI-UHFFFAOYSA-N 1h-pyridazin-6-one Chemical class OC1=CC=CN=N1 AAILEWXSEQLMNI-UHFFFAOYSA-N 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 9
- LGRDMGNIRNCULV-UHFFFAOYSA-N 2h-thiepino[4,5-c]pyridazin-3-one Chemical compound C1=CSC=CC2=NNC(=O)C=C21 LGRDMGNIRNCULV-UHFFFAOYSA-N 0.000 description 7
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 7
- 235000019341 magnesium sulphate Nutrition 0.000 description 7
- 238000010898 silica gel chromatography Methods 0.000 description 7
- 239000005457 ice water Substances 0.000 description 6
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 5
- 230000003647 oxidation Effects 0.000 description 5
- 238000007254 oxidation reaction Methods 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 4
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 4
- 229910052794 bromium Inorganic materials 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 230000000949 anxiolytic effect Effects 0.000 description 3
- 239000000460 chlorine Substances 0.000 description 3
- 230000007123 defense Effects 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 150000002431 hydrogen Chemical class 0.000 description 3
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 3
- 239000012046 mixed solvent Substances 0.000 description 3
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- DSKPZHRMHYDUHZ-UHFFFAOYSA-N 2-(4-chlorophenyl)-4,4a,5,6-tetrahydro-[1]benzothiepino[5,4-c]pyridazin-3-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)CC(CCSC=2C3=CC=CC=2)C3=N1 DSKPZHRMHYDUHZ-UHFFFAOYSA-N 0.000 description 2
- IMDOWZSYSHEDNZ-UHFFFAOYSA-N 2-phenyl-5,6-dihydrobenzo[h]cinnolin-3-one Chemical compound O=C1C=C2CCC3=CC=CC=C3C2=NN1C1=CC=CC=C1 IMDOWZSYSHEDNZ-UHFFFAOYSA-N 0.000 description 2
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- GLFHMYMOGBMFKJ-UHFFFAOYSA-N 10-chloro-2-(4-chlorophenyl)-5,6-dihydro-[1]benzothiepino[5,4-c]pyridazin-3-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C=C(CCSC=2C3=CC(Cl)=CC=2)C3=N1 GLFHMYMOGBMFKJ-UHFFFAOYSA-N 0.000 description 1
- 125000004778 2,2-difluoroethyl group Chemical group [H]C([H])(*)C([H])(F)F 0.000 description 1
- SPDFCDUCLRSDFJ-UHFFFAOYSA-N 2,5-dihydrothiochromeno[4,3-c]pyridazin-3-one Chemical compound C1=CC=C2C3=NNC(=O)C=C3CSC2=C1 SPDFCDUCLRSDFJ-UHFFFAOYSA-N 0.000 description 1
- OQTSXIJQJPCVIU-UHFFFAOYSA-N 2-(3,4-dichlorophenyl)-10-fluoro-5,6-dihydro-[1]benzothiepino[5,4-c]pyridazin-3-one Chemical compound N1=C2C3=CC(F)=CC=C3SCCC2=CC(=O)N1C1=CC=C(Cl)C(Cl)=C1 OQTSXIJQJPCVIU-UHFFFAOYSA-N 0.000 description 1
- CDXGDOAOYZJBAQ-UHFFFAOYSA-N 2-(4-chlorophenyl)-10-fluoro-5,6-dihydro-[1]benzothiepino[5,4-c]pyridazin-3-one Chemical compound N1=C2C3=CC(F)=CC=C3SCCC2=CC(=O)N1C1=CC=C(Cl)C=C1 CDXGDOAOYZJBAQ-UHFFFAOYSA-N 0.000 description 1
- VIFGKSBYGOOBBG-UHFFFAOYSA-N 2-(4-chlorophenyl)-10-methyl-5,6-dihydro-[1]benzothiepino[5,4-c]pyridazin-3-one Chemical compound N1=C2C3=CC(C)=CC=C3SCCC2=CC(=O)N1C1=CC=C(Cl)C=C1 VIFGKSBYGOOBBG-UHFFFAOYSA-N 0.000 description 1
- YBMQDCOBSZOXKX-UHFFFAOYSA-N 2-(4-chlorophenyl)-10-methyl-5,6-dihydro-[1]benzoxepino[5,4-c]pyridazin-3-one Chemical compound CC1=CC2=C(C=C1)OCCC3=CC(=O)N(N=C32)C4=CC=C(C=C4)Cl YBMQDCOBSZOXKX-UHFFFAOYSA-N 0.000 description 1
- HGTKXLSACZIAPO-UHFFFAOYSA-N 2-(4-chlorophenyl)-4,4a,5,6-tetrahydrothieno[1,2]thiepino[3,4-d]pyridazin-3-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)CC(CCSC2=C3C=CS2)C3=N1 HGTKXLSACZIAPO-UHFFFAOYSA-N 0.000 description 1
- HLHWQIOXHCZLNE-UHFFFAOYSA-N 2-(4-chlorophenyl)-6-oxo-4a,5-dihydro-4h-thiochromeno[4,3-c]pyridazin-3-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)CC(CS(=O)C=2C3=CC=CC=2)C3=N1 HLHWQIOXHCZLNE-UHFFFAOYSA-N 0.000 description 1
- WMEOBRROJNKGBB-UHFFFAOYSA-N 2-(4-chlorophenyl)-9-fluoro-5,6-dihydrobenzo[h]cinnolin-3-one Chemical compound N1=C2C3=CC(F)=CC=C3CCC2=CC(=O)N1C1=CC=C(Cl)C=C1 WMEOBRROJNKGBB-UHFFFAOYSA-N 0.000 description 1
- RTKLDILCUBBEPF-UHFFFAOYSA-N 2-(4-chlorophenyl)-9-methyl-5,6-dihydrobenzo[h]cinnolin-3-one Chemical compound N1=C2C3=CC(C)=CC=C3CCC2=CC(=O)N1C1=CC=C(Cl)C=C1 RTKLDILCUBBEPF-UHFFFAOYSA-N 0.000 description 1
- RDHNMLDPFCTDAY-UHFFFAOYSA-N 2-[3-(trifluoromethyl)phenyl]-5,6-dihydrobenzo[h]cinnolin-3-one Chemical compound FC(F)(F)C1=CC=CC(N2C(C=C3C(C4=CC=CC=C4CC3)=N2)=O)=C1 RDHNMLDPFCTDAY-UHFFFAOYSA-N 0.000 description 1
- RZBPHUICFWALGY-UHFFFAOYSA-N 2H-[1]benzoxepino[5,4-c]pyridazin-3-one Chemical compound N=1NC(C=C2C1C1=C(OC=C2)C=CC=C1)=O RZBPHUICFWALGY-UHFFFAOYSA-N 0.000 description 1
- 125000004800 4-bromophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Br 0.000 description 1
- PFPIXXYLPBSKBY-UHFFFAOYSA-N 8-chloro-2-(4-chlorophenyl)-5,6-dihydro-[1]benzothiepino[5,4-c]pyridazin-3-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C=C(CCSC=2C3=CC=CC=2Cl)C3=N1 PFPIXXYLPBSKBY-UHFFFAOYSA-N 0.000 description 1
- REEGWDCMRHYQRK-UHFFFAOYSA-N 8-chloro-2-(4-chlorophenyl)-5,6-dihydrobenzo[h]cinnolin-3-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C=C(CCC=2C3=CC=C(Cl)C=2)C3=N1 REEGWDCMRHYQRK-UHFFFAOYSA-N 0.000 description 1
- QYCIMIGOSJSCRX-UHFFFAOYSA-N 8-chloro-2-phenyl-5,6-dihydrobenzo[h]cinnolin-3-one Chemical compound C=1C(Cl)=CC=C(C2=N3)C=1CCC2=CC(=O)N3C1=CC=CC=C1 QYCIMIGOSJSCRX-UHFFFAOYSA-N 0.000 description 1
- VDEHTBMYQCSBBA-UHFFFAOYSA-N 9-chloro-2-(4-chlorophenyl)-5,6-dihydrobenzo[h]cinnolin-3-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C=C(CCC=2C3=CC(Cl)=CC=2)C3=N1 VDEHTBMYQCSBBA-UHFFFAOYSA-N 0.000 description 1
- RXCXJIILLAPWNO-UHFFFAOYSA-N 9-chloro-2-(4-fluorophenyl)-5,6-dihydrobenzo[h]cinnolin-3-one Chemical compound C1=CC(F)=CC=C1N1C(=O)C=C(CCC=2C3=CC(Cl)=CC=2)C3=N1 RXCXJIILLAPWNO-UHFFFAOYSA-N 0.000 description 1
- XPTYARAPPSMIMV-UHFFFAOYSA-N 9-chloro-2-(4-methylphenyl)-5,6-dihydrobenzo[h]cinnolin-3-one Chemical compound C1=CC(C)=CC=C1N1C(=O)C=C(CCC=2C3=CC(Cl)=CC=2)C3=N1 XPTYARAPPSMIMV-UHFFFAOYSA-N 0.000 description 1
- OLAJYNRBCYWQKB-UHFFFAOYSA-N 9-chloro-2-(4-nitrophenyl)-5,6-dihydrobenzo[h]cinnolin-3-one Chemical compound C1=CC([N+](=O)[O-])=CC=C1N1C(=O)C=C(CCC=2C3=CC(Cl)=CC=2)C3=N1 OLAJYNRBCYWQKB-UHFFFAOYSA-N 0.000 description 1
- UJMUUICTGQZSGP-UHFFFAOYSA-N 9-chloro-2-phenyl-5,6-dihydrobenzo[h]cinnolin-3-one Chemical compound N1=C2C3=CC(Cl)=CC=C3CCC2=CC(=O)N1C1=CC=CC=C1 UJMUUICTGQZSGP-UHFFFAOYSA-N 0.000 description 1
- CLWAKHSWKDGYEC-UHFFFAOYSA-N 9-fluoro-2-phenyl-5,6-dihydrobenzo[h]cinnolin-3-one Chemical compound N1=C2C3=CC(F)=CC=C3CCC2=CC(=O)N1C1=CC=CC=C1 CLWAKHSWKDGYEC-UHFFFAOYSA-N 0.000 description 1
- LSWIFDUFOAAFCQ-UHFFFAOYSA-N 9-methyl-2-(4-methylphenyl)-5,6-dihydrobenzo[h]cinnolin-3-one Chemical compound C1=CC(C)=CC=C1N1C(=O)C=C(CCC=2C3=CC(C)=CC=2)C3=N1 LSWIFDUFOAAFCQ-UHFFFAOYSA-N 0.000 description 1
- RFUMLTPZYNGISZ-UHFFFAOYSA-N 9-methyl-2-phenyl-5,6-dihydrobenzo[h]cinnolin-3-one Chemical compound N1=C2C3=CC(C)=CC=C3CCC2=CC(=O)N1C1=CC=CC=C1 RFUMLTPZYNGISZ-UHFFFAOYSA-N 0.000 description 1
- FVPFNZUYHBKKGC-UHFFFAOYSA-N C1COC2=C(C=C(C=C2)Br)C3=NN(C(=O)C=C31)C4=CC=C(C=C4)Cl Chemical compound C1COC2=C(C=C(C=C2)Br)C3=NN(C(=O)C=C31)C4=CC=C(C=C4)Cl FVPFNZUYHBKKGC-UHFFFAOYSA-N 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- YXIVOZHEBYECIE-UHFFFAOYSA-N N=1NC(C=C2C=1C=CS(C=C2)=O)=O Chemical compound N=1NC(C=C2C=1C=CS(C=C2)=O)=O YXIVOZHEBYECIE-UHFFFAOYSA-N 0.000 description 1
- RSMGUJKQCYPZQW-UHFFFAOYSA-N O=C1CC2CCC3=CC=CC=C3C2=NN1C1=CC=CC=C1 Chemical compound O=C1CC2CCC3=CC=CC=C3C2=NN1C1=CC=CC=C1 RSMGUJKQCYPZQW-UHFFFAOYSA-N 0.000 description 1
- MNZMECMQTYGSOI-UHFFFAOYSA-N acetic acid;hydron;bromide Chemical compound Br.CC(O)=O MNZMECMQTYGSOI-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 125000005997 bromomethyl group Chemical group 0.000 description 1
- 125000004744 butyloxycarbonyl group Chemical group 0.000 description 1
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 description 1
- 125000000068 chlorophenyl group Chemical group 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229910000042 hydrogen bromide Inorganic materials 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000005929 isobutyloxycarbonyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])OC(*)=O 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000005928 isopropyloxycarbonyl group Chemical group [H]C([H])([H])C([H])(OC(*)=O)C([H])([H])[H] 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 125000004998 naphthylethyl group Chemical group C1(=CC=CC2=CC=CC=C12)CC* 0.000 description 1
- 125000004923 naphthylmethyl group Chemical group C1(=CC=CC2=CC=CC=C12)C* 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 125000000286 phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004344 phenylpropyl group Chemical group 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004742 propyloxycarbonyl group Chemical group 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- TVPRCLHSULCNLV-UHFFFAOYSA-N pyridazin-3-one Chemical compound O=C1C=CC=N[N]1 TVPRCLHSULCNLV-UHFFFAOYSA-N 0.000 description 1
- 125000002098 pyridazinyl group Chemical group 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- RUPAXCPQAAOIPB-UHFFFAOYSA-N tert-butyl formate Chemical group CC(C)(C)OC=O RUPAXCPQAAOIPB-UHFFFAOYSA-N 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Description
【発明の詳細な説明】 〔産業上の利用分野〕 本発明は選択的な抗不安作用、生体防御能亢進作用など
の有用な薬理作用を有し、医薬として有用なピリダジノ
ン化合物の新規製造法に関する。DETAILED DESCRIPTION OF THE INVENTION [Industrial field of use] The present invention relates to a novel method for producing a pyridazinone compound having a useful pharmacological action such as selective anxiolytic action and biological defense enhancing action. .
特開昭61−56169号公報、同62−252789号公報、特開平
1−9991号公報、同1−6278号公報、同1−228969号公
報、同1−250383号公報には抗不安作用あるいは生体防
御能亢進作用などを有する各種のピリダジノン化合物が
示されている。JP-A-61-56169, JP-A-62-252789, JP-A-1-9991, JP-A-1-6278, JP-A1-228969, and JP-A-1-250383 have an anxiolytic effect or Various pyridazinone compounds having a biological defense enhancing action have been shown.
一方、ジャーナル・オブ・メディシナル・ケミストリー
(Journal of Medicinal Chemistry)第14巻、262頁(1
971年)には、ピリダジノン環の4,5位に二重結合を導入
する方法として臭素による酸化が報告され、また英国特
許第1168291号には、メタニトロベンゼンスルホン酸ナ
トリウムによる酸化が報告されている。前記公開公報に
おいては、ピリダジノン環の4,5位に二重結合を導入す
る方法としてこれらの方法が用いられている。Meanwhile, Journal of Medicinal Chemistry, Vol. 14, p. 262 (1
(971) reported oxidation with bromine as a method of introducing a double bond at the 4,5-position of the pyridazinone ring, and British Patent No. 1168291 reported oxidation with sodium metanitrobenzenesulfonate. . In the above-mentioned publication, these methods are used as a method for introducing a double bond at the 4- and 5-positions of the pyridazinone ring.
ところが、臭素による酸化で二重結合を導入する方法で
は臭素化された副生成物が混入し、またメタニトロベン
ゼンスルホン酸ナトリウムによる酸化では、ピリダジノ
ン環がアルカリに不安定で分解するおそれがあるなど解
決すべき問題が多い。However, in the method of introducing a double bond by oxidation with bromine, a brominated by-product is mixed, and in the oxidation with sodium metanitrobenzenesulfonate, the pyridazinone ring may be unstable and decomposed into alkali, which may be a problem. There are many problems to be solved.
本発明者らは、これらの問題点を解決すべく鋭意検討し
た結果、ジメチルスルホキシドなどのスルホキシドの存
在下まは非存在下、酸との反応により緩和な条件下ピリ
ダジノン環の4,5位に二重結合を導入する新規方法を見
出し、本発明を完成するに至った。The present inventors have conducted extensive studies to solve these problems, and as a result, in the presence or absence of a sulfoxide such as dimethyl sulfoxide, in the 4,5-position of the pyridazinone ring under mild conditions by reaction with an acid. The inventors have found a novel method for introducing a double bond and have completed the present invention.
すなわち、本発明は一般式 〔式中、環Aはベンゼン環またはチオフェン環を、R1,R
2は同一または異なって、水素、ハロゲン、トリフルオ
ロメチル、ヒドロキシ、アミノ、ニトロ、シアノ、低級
アルキル、低級アルコキシまたは低級アルカノイルアミ
ノを、R3は水素、炭素数1〜8個を有するアルキル、ヒ
ドロキシアルキル、アルカノイルオキシアルキル、アリ
ール、アラルキル、ヘテロアリールまたは芳香環上にハ
ロゲン、ヒドロキシ、アミノ、ニトロ、シアノ、低級ア
ルキル、低級アルコキシ、低級アルカノイルアミノ、ハ
ロアルキル、アシルオキシ、低級アルコキシカルボニル
およびカルボキシから選ばれる置換基を少なくとも1個
有しているアリール、アラルキルもしくはヘテロアリー
ルを、XはO,S,SO,SO2,CH2またはNR4(R4は水素、低級
アルキル、アシルまたはベンゼンスルホニルを示す。)
を、nは1または2を示す。〕 により表わされる化合物を、必要によりスルホキシド化
合物の存在下、酸と反応させることを特徴とする一般式 (式中、各記号は前記と同義である。) により表わされるピリダジノン化合物の製造法を提供す
る。That is, the present invention has the general formula Wherein ring A benzene ring or thiophene ring, R 1, R
2 is the same or different and is hydrogen, halogen, trifluoromethyl, hydroxy, amino, nitro, cyano, lower alkyl, lower alkoxy or lower alkanoylamino, R 3 is hydrogen, alkyl having 1 to 8 carbons, hydroxy Substitution selected from halogen, hydroxy, amino, nitro, cyano, lower alkyl, lower alkoxy, lower alkanoylamino, haloalkyl, acyloxy, lower alkoxycarbonyl and carboxy on alkyl, alkanoyloxyalkyl, aryl, aralkyl, heteroaryl or aromatic ring. An aryl, aralkyl or heteroaryl having at least one group, X is O, S, SO, SO 2 , CH 2 or NR 4 (R 4 represents hydrogen, lower alkyl, acyl or benzenesulfonyl).
And n represents 1 or 2. ] The compound represented by the formula is reacted with an acid in the presence of a sulfoxide compound, if necessary. (In the formula, each symbol has the same meaning as defined above.) A method for producing a pyridazinone compound represented by
上記定義中、ハロゲンとは塩素、臭素、フッ素、ヨウ素
を、低級アルキルとはメチル、エチル、プロピル、イソ
プロピル、ブチル、イソブチル、第3級ブチルなどを、
低級アルコキシとはメトキシ、エトキシ、プロポキシ、
イソプロポキシ、ブトキシ、イソブトキシ、第3級ブト
キシなどを、低級アルカノイルアミノとはアセチルアミ
ノ、プロピオニルアミノ、ブチリルアミノ、ピバロイル
アミノなどを、炭素数1〜8個を有するアルキルとは直
鎖または分枝鎖状で、メチル、エチル、プロピル、イソ
プロピル、ブチル、第2級ブチル、第3級ブチル、ペン
チル、イソペンチル、ネオペンチル、ヘキシル、ヘプチ
ル、オクチル、2−エチルヘキシルなどを、ヒドロキシ
アルキルとはヒドロキシメチル、ヒドロキシエチル、ヒ
ドロキシプロピル、ヒドロキシブチルなどを、アルカノ
イルオキシアルキルとはアセトキシメチル、アセトキシ
エチル、アセトキシプロピル、アセトキシブチル、プロ
ピオニルオキシメチル、プロピオニルオキシエチル、プ
ロピオニルオキシプロピル、プロピオニルオキシブチル
などを、アリールとはフェニル、ナフチルなどを、アラ
ルキルとはベンジル、フェニルエチル、フェニルプロピ
ル、フェニルブチル、ナフチルメチル、ナフチルエチ
ル、ナフチルプロピル、ナフチルブチルなどを、ヘテロ
アリールとはピリジル、チエニル、フリル、ピラゾリ
ル、イミダゾリル、ピリミジニル、ピリダジニル、ベン
ズイミダゾリルなどを、ハロアルキルとはフルオロメチ
ル、ブロモメチル、クロロメチル、ヨードメチル、ジフ
ルオロメチル、トリフルオロメチル、2,2−ジフルオロ
エチル、2,2,2−トリフルオロエチルなどを、アシルオ
キシとはアセチルオキシ、プロピオニルオキシ、ブチリ
ルオキシ、イソブチリルオキシ、ベンゾイルオキシなど
を、低級アルコキシカルボニルとはメトキシカルボニ
ル、エトキシカルボニル、プロポキシカルボニル、イソ
プロポキシカルボニル、ブトシキカルボニル、イソブト
キシカルボニル、第3級ブトキシカルボニルなどを、ア
シルとはアセチル、プロピオニル、ブチリル、イソブチ
リル、ベンゾイルなどを示す。In the above definition, halogen is chlorine, bromine, fluorine and iodine, and lower alkyl is methyl, ethyl, propyl, isopropyl, butyl, isobutyl, tertiary butyl, etc.
Lower alkoxy is methoxy, ethoxy, propoxy,
Isopropoxy, butoxy, isobutoxy, tertiary butoxy and the like, lower alkanoylamino is acetylamino, propionylamino, butyrylamino, pivaloylamino and the like, and alkyl having 1 to 8 carbons is a straight or branched chain. , Methyl, ethyl, propyl, isopropyl, butyl, secondary butyl, tertiary butyl, pentyl, isopentyl, neopentyl, hexyl, heptyl, octyl, 2-ethylhexyl and the like, and hydroxyalkyl is hydroxymethyl, hydroxyethyl, hydroxy. Propyl, hydroxybutyl, etc. are alkanoyloxyalkyl and acetoxymethyl, acetoxyethyl, acetoxypropyl, acetoxybutyl, propionyloxymethyl, propionyloxyethyl, propionyloxy. Ropyl, propionyloxybutyl, etc., aryl is phenyl, naphthyl, etc., aralkyl is benzyl, phenylethyl, phenylpropyl, phenylbutyl, naphthylmethyl, naphthylethyl, naphthylpropyl, naphthylbutyl, etc., and heteroaryl is pyridyl. , Thienyl, furyl, pyrazolyl, imidazolyl, pyrimidinyl, pyridazinyl, benzimidazolyl and the like, and haloalkyl is fluoromethyl, bromomethyl, chloromethyl, iodomethyl, difluoromethyl, trifluoromethyl, 2,2-difluoroethyl, 2,2,2. -Trifluoroethyl, etc., acyloxy is acetyloxy, propionyloxy, butyryloxy, isobutyryloxy, benzoyloxy, etc., and lower alkoxycarbonyl is methoxycarboxyl. Rubonyl, ethoxycarbonyl, propoxycarbonyl, isopropoxycarbonyl, butoxycarbonyl, isobutoxycarbonyl, tertiary butoxycarbonyl and the like, and acyl means acetyl, propionyl, butyryl, isobutyryl, benzoyl and the like.
本発明方法による一般式(I)の化合物の製造法は次の
通りである。The method for producing the compound of general formula (I) according to the method of the present invention is as follows.
方法1 一般式 (式中、各記号は前記と同義である。) により表わされるスルホキシド化合物を適当な酸(臭化
水素酸、塩酸、ヨウ化水素酸などのハロゲン化水素酸、
メタンスルホン酸、トリフルオロメタンスルホン酸など
のアルキルスルホン酸、酢酸、ギ酸、トリフルオロ酢酸
などの脂肪族カルボン酸、p−トルエンスルホン酸など
のアリールスルホン酸など、またはその混合物)中、1
〜数十時間にわたり、0℃から酸の沸点付近で反応させ
る方法。Method 1 General formula (In the formula, each symbol has the same meaning as defined above.) A sulfoxide compound represented by the following formula is used as a suitable acid (hydrobromic acid such as hydrobromic acid, hydrochloric acid or hydroiodic acid,
Alkylsulfonic acid such as methanesulfonic acid and trifluoromethanesulfonic acid, aliphatic carboxylic acid such as acetic acid, formic acid and trifluoroacetic acid, arylsulfonic acid such as p-toluenesulfonic acid, and the like, or a mixture thereof)
~ A method of reacting from 0 ° C to around the boiling point of the acid for several tens of hours.
好ましくは、一般式(II)−1の化合物をトリフルオロ
酢酸中、15〜25時間加熱還流するか、酢酸中、臭化水素
の存在下、室温下に撹拌するか、またはメタンスルホン
酸中、60〜80℃にて15分〜数十時間撹拌することにより
製造することができる。Preferably, the compound of the general formula (II) -1 is heated under reflux in trifluoroacetic acid for 15 to 25 hours, stirred in acetic acid in the presence of hydrogen bromide at room temperature, or in methanesulfonic acid. It can be produced by stirring at 60 to 80 ° C for 15 minutes to several tens of hours.
方法2 一般式 (式中、各記号は前記と同義である。) により表わされる化合物を、スルホキシド(ジメチルス
ルホキシド、ジフェニルスルホキシド、フェニルビニル
スルホキシド、ジベンジルスルホキシド、p−トリルス
ルホキシド、メチルフェニルスルホキシド、レゾルシノ
ールスルホキシドなど)の存在下、適当な酸(方法1に
同じ)中、数分から数十時間にわたり0℃から溶媒の還
流温度で撹拌する方法。Method 2 General formula (In the formula, each symbol has the same meaning as described above.), A compound represented by the following formula is used as a sulfoxide (dimethyl sulfoxide, diphenyl sulfoxide, phenyl vinyl sulfoxide, dibenzyl sulfoxide, p-tolyl sulfoxide, methylphenyl sulfoxide, resorcinol sulfoxide, etc.). A method of stirring in the presence of a suitable acid (the same as in Method 1) at 0 ° C. to the reflux temperature of the solvent for several minutes to several tens hours.
好ましくは、一般式(II)−2の化合物をメタンスルホ
ン酸に溶解させ、ジメチルスルホキシド4当量の存在下
80〜90℃にて10〜25時間撹拌することにより製造するこ
とができる。Preferably, the compound of the general formula (II) -2 is dissolved in methanesulfonic acid, and in the presence of 4 equivalents of dimethylsulfoxide.
It can be produced by stirring at 80 to 90 ° C for 10 to 25 hours.
なお、一般式(II)の化合物は従来技術の欄に示した公
開公報に記載されている方法によって製造することがで
きる。The compound of general formula (II) can be produced by the method described in the publication of the prior art.
本発明方法によれば、緩和な条件下でピリダジノン環の
4,5位に効率よく二重結合を導入することができ、ま
た、従来の臭素による酸化方法でみられた臭素化された
副生成物が混入することもない。従って、本発明方法は
一般式(I)で表わされる化合物の工業的に有利な方法
である。According to the method of the present invention, the pyridazinone ring of
A double bond can be efficiently introduced at the 4,5-position, and the brominated by-product found in the conventional bromine oxidation method is not mixed. Therefore, the method of the present invention is an industrially advantageous method for the compound represented by the general formula (I).
また、得られる一般式(I)の化合物は抗不安作用、生
体防御能亢進作用などを有し、医薬として有用である。In addition, the obtained compound of the general formula (I) has anxiolytic action, biological defense enhancing action and the like, and is useful as a medicine.
以下、本発明を実施例により具体的に説明するが、本発
明はこれらに限定されるもではない。Hereinafter, the present invention will be specifically described by way of examples, but the present invention is not limited thereto.
実施例1 2−(4−クロロフェニル)−4,4a,5,6−テトラヒドロ
チエノ〔2′,3′:2,3〕チエピノ〔4,5−c〕ピリダジ
ン−3(2H)−オン 7−オキサイド5.6gのメタンスル
ホン酸50ml溶液を60℃にて2時間保持する。のち反応液
を氷水中に注ぎ、クロロホルムにて抽出後、水洗し、硫
酸マグネシウムにて乾燥する。クロロホルムを留去し、
得られた残査をシリカゲルカラムクロマトに付し、クロ
ロホルムおよびメタノールの混合溶媒(100:1)より溶
出する画分から得られる粗結晶を酢酸エチルより再結晶
を行なうと、融点140〜142℃の白色結晶として2−(4
−クロロフェニル)−5,6−ジヒドロチエノ〔2′,3′:
2,3〕チエピノ〔4,5−c〕ピリダジン−3(2H)−オン
2.2gが得られる。Example 1 2- (4-chlorophenyl) -4,4a, 5,6-tetrahydrothieno [2 ', 3': 2,3] thiepino [4,5-c] pyridazin-3 (2H) -one 7- A solution of 5.6 g of oxide in 50 ml of methanesulfonic acid is kept at 60 ° C. for 2 hours. After that, the reaction solution is poured into ice water, extracted with chloroform, washed with water, and dried with magnesium sulfate. Distill off the chloroform,
The obtained residue was subjected to silica gel column chromatography, and crude crystals obtained from the fraction eluted with a mixed solvent of chloroform and methanol (100: 1) were recrystallized from ethyl acetate to give a white powder with a melting point of 140 to 142 ° C. 2- (4 as crystals
-Chlorophenyl) -5,6-dihydrothieno [2 ', 3':
2,3] thiepino [4,5-c] pyridazin-3 (2H) -one
2.2 g are obtained.
実施例2 実施例1で用いた2−(4−クロロフェニル)−4,4a,
5,6−テトラヒドロチエノ〔2′,3′:2,3〕チエピノ
〔4,5−c〕ピリダジン−3(2H)−オン 7−オキサ
イドの代わりに9−ブロモ−2−(4−メトキシフェニ
ル)−4,4a,5,6−テトラヒドロチエノ〔2′,3′:2,3〕
チエピノ〔4,5−c〕ピリダジン−3(2H)−オン 7
−オキサイドを用いて同様の反応および処理を行なうこ
とにより、融点148〜150℃の白色結晶として9−ブロモ
−2−(4−メトキシフェニル)−5,6−ジヒドロチエ
ノ〔2′,3′:2,3〕チエピノ〔4,5−c〕ピリダジン−
3(2H)−オンが得られる。Example 2 2- (4-chlorophenyl) -4,4a used in Example 1,
5,6-Tetrahydrothieno [2 ', 3': 2,3] thiepino [4,5-c] pyridazin-3 (2H) -one 9-Bromo-2- (4-methoxyphenyl) instead of 7-oxide ) -4,4a, 5,6-Tetrahydrothieno [2 ', 3': 2,3]
Thiepino [4,5-c] pyridazin-3 (2H) -one 7
By the same reaction and treatment with -oxide, 9-bromo-2- (4-methoxyphenyl) -5,6-dihydrothieno [2 ', 3': 2 was obtained as white crystals having a melting point of 148 to 150 ° C. , 3] Thiepino [4,5-c] pyridazine-
3 (2H) -one is obtained.
実施例3 実施例1で用いた2−(4−クロロフェニル)−4,4a,
5,6−テトラヒドロチエノ〔2′,3′:2,3〕チエピノ
〔4,5−c〕ピリダジン−3(2H)−オン 7−オキサ
イドの代わりに9−エチル−2−(4−メトキシフェニ
ル)−4,4a,5,6−テトラヒドロチエノ〔2′,3′:2,3〕
チエピノ〔4,5−c〕ピリダジン−3(2H)−オン 7
−オキサイドを用いて同様の反応および処理を行なうこ
とにより、融点141〜143℃の白色結晶として9−エチル
−2−(4−メトキシフェニル)−5,6−ジヒドロチエ
ノ〔2′,3′:2,3〕チエピノ〔4,5−c〕ピリダジン−
3(2H)−オンが得られる。Example 3 2- (4-chlorophenyl) -4,4a used in Example 1,
5,6-Tetrahydrothieno [2 ', 3': 2,3] thiepino [4,5-c] pyridazin-3 (2H) -one 7-oxide instead of 9-ethyl-2- (4-methoxyphenyl) ) -4,4a, 5,6-Tetrahydrothieno [2 ', 3': 2,3]
Thiepino [4,5-c] pyridazin-3 (2H) -one 7
By performing the same reaction and treatment with -oxide, 9-ethyl-2- (4-methoxyphenyl) -5,6-dihydrothieno [2 ', 3': 2] was obtained as white crystals having a melting point of 141-143 ° C. , 3] Thiepino [4,5-c] pyridazine-
3 (2H) -one is obtained.
実施例4 実施例1で用いた2−(4−クロロフェニル)−4,4a,
5,6−テトラヒドロチエノ〔2′,3′:2,3〕チエピノ
〔4,5−c〕ピリダジン−3(2H)−オン 7−オキサ
イドの代わりに2−(4−メトキシフェニル)−9−メ
チル−4,4a,5,6−テトラヒドロチエノ〔2′,3′:2,3〕
チエピノ〔4,5−c〕ピリダジン−3(2H)−オン 7
−オキサイドを用いて同様の反応および処理を行なうこ
とにより、融点145〜146℃の白色結晶として2−(4−
メトキシフェニル)−9−メチル−5,6−ジヒドロチエ
ノ〔2′,3′:2,3〕チエピノ〔4,5−c〕ピリダジン−
3(2H)−オンが得られる。Example 4 2- (4-chlorophenyl) -4,4a used in Example 1
5,6-Tetrahydrothieno [2 ', 3': 2,3] thiepino [4,5-c] pyridazin-3 (2H) -one 2- (4-methoxyphenyl) -9-instead of 7-oxide Methyl-4,4a, 5,6-tetrahydrothieno [2 ', 3': 2,3]
Thiepino [4,5-c] pyridazin-3 (2H) -one 7
-By performing the same reaction and treatment with oxide, 2- (4-
Methoxyphenyl) -9-methyl-5,6-dihydrothieno [2 ', 3': 2,3] thiepino [4,5-c] pyridazine-
3 (2H) -one is obtained.
実施例5 2−(4−メトキシフェニル)−4,4a,5,6−テトラヒド
ロ〔2′,3′:2,3〕チエピノ〔4,5−c〕ピリダジン−
3(2H)−オン14.8gの30%臭化水素酢酸100ml溶液へ室
温にて撹拌下、ジメチルスルホキシド6.1mlを加える。
のち、室温にて4時間反応後、反応液を水にあけ、クロ
ロホルムにて抽出し、水洗、乾燥する。減圧濃縮し、得
られた結晶をトルエン−イソプロピルエーテルの混合溶
媒より再結晶を行なうと、融点126〜128℃の白色結晶と
して2−(4−メトキシフェニル)−5,6−ジヒドロチ
エノ〔2′,3′:2,3〕チエピノ〔4,5−c〕ピリダジン
−3(2H)−オン10gが得られる。Example 5 2- (4-Methoxyphenyl) -4,4a, 5,6-tetrahydro [2 ', 3': 2,3] thiepino [4,5-c] pyridazine-
To a solution of 14.8 g of 3 (2H) -one in 100 ml of 30% hydrobromic acid, 6.1 ml of dimethyl sulfoxide was added with stirring at room temperature.
Then, after reacting for 4 hours at room temperature, the reaction solution is poured into water, extracted with chloroform, washed with water and dried. The crystals obtained were concentrated under reduced pressure, and the obtained crystals were recrystallized from a mixed solvent of toluene-isopropyl ether to give 2- (4-methoxyphenyl) -5,6-dihydrothieno [2 ', white crystals having a melting point of 126 to 128 ° C. 10 g of 3 ': 2,3] thiepino [4,5-c] pyridazin-3 (2H) -one are obtained.
実施例6 2−(4−クロロフェニル)−4,4a,5,6−テトラヒドロ
−〔1〕ベンゾチエピノ〔5,4−c〕ピリダジン−3(2
H)−オン 7−オキサイド2gのトリフルオロ酢酸溶液
を15時間還流する。のち、反応液を氷水中に注ぎ、クロ
ロホルムにて抽出後水洗し、硫酸マグネシウムにて乾燥
する。クロロホルムを留去し、得られた残査をシリカゲ
ルカラムクロマトに付し、クロロホルムより溶出する画
分から得られる粗結晶をエタノールより再結晶を行なう
と、融点186〜187℃の白色結晶として2−(4−クロロ
フェニル)−5,6−ジヒドロ−〔1〕ベンゾチエピノ
〔5,4−c〕ピリダジン−3(2H)−オン0.9gが得られ
る。Example 6 2- (4-chlorophenyl) -4,4a, 5,6-tetrahydro- [1] benzothiepino [5,4-c] pyridazine-3 (2
A solution of 2 g of H) -one 7-oxide in trifluoroacetic acid is refluxed for 15 hours. After that, the reaction solution is poured into ice water, extracted with chloroform, washed with water, and dried with magnesium sulfate. Chloroform was distilled off, the obtained residue was subjected to silica gel column chromatography, and crude crystals obtained from the fraction eluted from chloroform were recrystallized from ethanol to give 2- () as white crystals having a melting point of 186 to 187 ° C. 0.9 g of 4-chlorophenyl) -5,6-dihydro- [1] benzothiepino [5,4-c] pyridazin-3 (2H) -one are obtained.
実施例7 2−(4−クロロフェニル)−4,4a,5,6−テトラヒドロ
−〔1〕ベンゾチエピノ〔5,4−c〕ピリダジン−3(2
H)−オン5gのメタンスルホン酸溶液にジメチルスルホ
キシド4当量を加え、70〜90℃にて15〜20時間撹拌す
る。のち、反応液を氷水中に注ぎ、クロロホルムにて抽
出後水洗し、硫酸マグネシウムにて乾燥する。クロロホ
ルムを留去し、得られた残査をシリカゲルカラムクロマ
トに付し、クロロホルムより溶出する画分から得られる
粗結晶をエタノールより再結晶を行なうと、融点186〜1
87℃の白色結晶として2−(4−クロロフェニル)−5,
6−ジヒドロ−〔1〕ベンゾチエピノ〔5,4−c〕ピリダ
ジン−3(2H)−オン 4.3gが得られる。Example 7 2- (4-chlorophenyl) -4,4a, 5,6-tetrahydro- [1] benzothiepino [5,4-c] pyridazine-3 (2
H) -one (5 g) was added to methanesulfonic acid solution (4 equivalents), and the mixture was stirred at 70 to 90 ° C for 15 to 20 hours. After that, the reaction solution is poured into ice water, extracted with chloroform, washed with water, and dried with magnesium sulfate. Chloroform was distilled off, the obtained residue was subjected to silica gel column chromatography, and crude crystals obtained from the fraction eluted from chloroform were recrystallized from ethanol to give a melting point of 186-1.
2- (4-chlorophenyl) -5 as white crystals at 87 ° C,
4.3 g of 6-dihydro- [1] benzothiepino [5,4-c] pyridazin-3 (2H) -one are obtained.
実施例8 2−(4−クロロフェニル)−4,4a,5,6−テトラヒドロ
−〔1〕ベンゾチエピノ〔5,4−c〕ピリダジン−3(2
H)−オン 7−オキサイド5gのメタンスルホン酸溶液
を70〜90℃にて15〜25時間撹拌する。のち、反応液を氷
水中に注ぎ、クロロホルムにて抽出後、水洗し、硫酸マ
グネシウムにて乾燥する。クロロホルムを留去し、得ら
れた残査をシリカゲルカラムクロマトに付し、クロロホ
ルムより溶出する画分から得られる粗結晶をエタノール
より再結晶を行なうと、融点186〜187℃の白色結晶とし
て2−(4−クロロフェニル)−5,6−ジヒドロ−
〔1〕ベンゾチエピノ〔5,4−c〕ピリダジン−3(2
H)−オン4.2gが得られる。Example 8 2- (4-chlorophenyl) -4,4a, 5,6-tetrahydro- [1] benzothiepino [5,4-c] pyridazine-3 (2
A solution of 5 g of H) -one 7-oxide in methanesulfonic acid is stirred at 70 to 90 ° C. for 15 to 25 hours. After that, the reaction solution is poured into ice water, extracted with chloroform, washed with water, and dried with magnesium sulfate. Chloroform was distilled off, the obtained residue was subjected to silica gel column chromatography, and crude crystals obtained from the fraction eluted from chloroform were recrystallized from ethanol to give 2- () as white crystals having a melting point of 186 to 187 ° C. 4-chlorophenyl) -5,6-dihydro-
[1] Benzothieno [5,4-c] pyridazine-3 (2
H) -one 4.2 g is obtained.
実施例9 2−(4−クロロフェニル)−4,4a,5,6−テトラヒドロ
−〔1〕ベンゾチエピノ〔5,4−c〕ピリダジン−3(2
H)−オン 7−オキサイド2gの臭化水素酢酸溶液を室
温下3〜5時間撹拌する。のち、反応液を氷水中に注
ぎ、クロロホルムにて抽出後水洗し、硫酸マグネシウム
にて乾燥する。クロロホルムを留去し、得られた残査を
シリカゲルカラムクロマトに付し、クロロホルムより溶
出する画分から得られる粗結晶をエタノールより再結晶
を行なうと、融点186〜187℃の白色結晶として2−(4
−クロロフェニル)−5,6−ジヒドロ−〔1〕ベンゾチ
エピノ〔5,4−c〕ピリダジン−3(2H)−オン1.8gが
得られる。Example 9 2- (4-chlorophenyl) -4,4a, 5,6-tetrahydro- [1] benzothiepino [5,4-c] pyridazine-3 (2
A solution of H) -one 7-oxide 2 g in hydrobromic acid was stirred at room temperature for 3 to 5 hours. After that, the reaction solution is poured into ice water, extracted with chloroform, washed with water, and dried with magnesium sulfate. Chloroform was distilled off, the obtained residue was subjected to silica gel column chromatography, and crude crystals obtained from the fraction eluted from chloroform were recrystallized from ethanol to give 2- () as white crystals having a melting point of 186 to 187 ° C. Four
1.8 g of -chlorophenyl) -5,6-dihydro- [1] benzothiepino [5,4-c] pyridazin-3 (2H) -one are obtained.
実施例10 2−(4−クロロフェニル)−4,4a,5,6−テトラヒドロ
−〔1〕ベンゾチエピノ〔5,4−c〕ピリダジン−3(2
H)オン5gの臭化水素酢酸溶液を室温にて15〜25分間撹
拌し、これにジメチルスルホキシド4当量を加え、室温
下30分間撹拌したのち、反応液を氷水中に注ぎ、クロロ
ホルムにて抽出後水洗し、硫酸マグネシウムにて乾燥す
る。クロロホルムを留去し、得られた残査をシリカゲル
クロマトに付し、クロロホルムより溶出する画分から得
られる粗結晶をエタノールより再結晶を行なうと、融点
186〜187℃の白色結晶として2−(4−クロロフェニ
ル)−5,6−ジヒドロ−〔1〕ベンゾチエピノ〔5,4−
c〕ピリダジン−3(2H)−オン4.5gが得られる。Example 10 2- (4-chlorophenyl) -4,4a, 5,6-tetrahydro- [1] benzothiepino [5,4-c] pyridazine-3 (2
H) on 5 g of hydrobromic acetic acid solution was stirred at room temperature for 15 to 25 minutes, 4 equivalents of dimethyl sulfoxide was added thereto, and the mixture was stirred at room temperature for 30 minutes, then the reaction solution was poured into ice water and extracted with chloroform. After that, it is washed with water and dried over magnesium sulfate. Chloroform was distilled off, the obtained residue was subjected to silica gel chromatography, and crude crystals obtained from the fraction eluted from chloroform were recrystallized from ethanol.
2- (4-chlorophenyl) -5,6-dihydro- [1] benzothiepino [5,4-] as white crystals at 186-187 ° C
4.5 g of c] pyridazin-3 (2H) -one are obtained.
実施例11 2−(4−クロロフェニル)−2,3,4,4a−テトラヒドロ
−5H−〔1〕ベンゾチオピラノ〔4,3−c〕ピリダジン
−3−オン 6−オキサイド5gのトリフルオロ酢酸溶液
を23時間還流し、実施例6と同様に処理を行なうことに
より、融点184〜185℃の2−(4−クロロフェニル)−
2,3−ジヒドロ−5H−〔1〕ベンゾチオピラノ〔4,3−
c〕ピリダジン−3−オン0.1gが得られる。Example 11 A solution of 2- (4-chlorophenyl) -2,3,4,4a-tetrahydro-5H- [1] benzothiopyrano [4,3-c] pyridazin-3-one 6-oxide 5g in trifluoroacetic acid was added to 23 By refluxing for a period of time and treating in the same manner as in Example 6, 2- (4-chlorophenyl) -having a melting point of 184 to 185 ° C.
2,3-Dihydro-5H- [1] benzothiopyrano [4,3-
c] Pyridazin-3-one 0.1 g is obtained.
実施例12 2−(4−クロロフェニル−3,4,4a,5,6,7−ヘキサヒド
ロ−2H−ベンゾ〔6,7〕シクロヘプタ〔1,2−c〕ピリダ
ジン−3−オン0.5gのメタンスルホン酸溶液12.5mlにジ
メチルスルホキシド4当量を加え、70〜80℃にて29時間
撹拌し、実施例7と同様に処理を行なうことにより、融
点167〜168℃の2−(4−クロロフェニル)−3,5,6,7
−テトラヒドロ−2H−ベンゾ〔6,7〕シクロヘプタ〔1,2
−c〕ピリダジン−3−オン0.14gが得られる。Example 12 2- (4-chlorophenyl-3,4,4a, 5,6,7-hexahydro-2H-benzo [6,7] cyclohepta [1,2-c] pyridazin-3-one 0.5 g methanesulfone To 12.5 ml of the acid solution, 4 equivalents of dimethyl sulfoxide was added, and the mixture was stirred at 70 to 80 ° C for 29 hours and treated in the same manner as in Example 7 to give 2- (4-chlorophenyl) -3 having a melting point of 167 to 168 ° C. , 5,6,7
-Tetrahydro-2H-benzo [6,7] cyclohepta [1,2
0.14 g of -c] pyridazin-3-one are obtained.
実施例13 2−(4−クロロフェニル)−2,3,4,4a,5,6−ヘキサヒ
ドロ〔1〕ベンズオキセピノ〔5,4−c〕ピリダジン−
3−オン0.5gのメタンスルホン酸溶液12.5mlにジメチル
スルホキシド4当量を加え、実施例7と同様に反応およ
び処理を行なうことにより、2−(4−クロロフェニ
ル)−2,3,5,6−テトラヒドロ〔1〕ベンズオキセピノ
〔5,4−c〕ピリダジン−3−オン0.15gが得られる。Example 13 2- (4-chlorophenyl) -2,3,4,4a, 5,6-hexahydro [1] benzoxepino [5,4-c] pyridazine-
2- (4-Chlorophenyl) -2,3,5,6- 0.15 g of tetrahydro [1] benzoxepino [5,4-c] pyridazin-3-one are obtained.
実施例14 2−フェニル−4,4a,5,6−テトラヒドロベンゾ〔h〕シ
ンノリン−3(2H)−オン0.5gのメタンスルホン酸溶液
12.5mlにジメチルスルホキシド4当量を加え、80〜90℃
にて18時間撹拌し、実施例7と同様に処理を行なうこと
により、融点165〜166℃の2−フェニル−5,6−ジヒド
ロベンゾ〔h〕シンノリン−3−(2H)−オン0.07gが
得られる。Example 14 2-Phenyl-4,4a, 5,6-tetrahydrobenzo [h] cinnolin-3 (2H) -one 0.5g methanesulfonic acid solution
Add 4 equivalents of dimethylsulfoxide to 12.5 ml, 80-90 ℃
After stirring for 18 hours and treating in the same manner as in Example 7, 0.07 g of 2-phenyl-5,6-dihydrobenzo [h] cinnolin-3- (2H) -one having a melting point of 165 to 166 ° C was obtained. can get.
実施例15 2−(4−クロロフェニル)−4,4a,5,6−テトラヒドロ
−〔1〕ベンゾチエピノ〔5,4−c〕ピリダジン−3(2
H)−オンをジフェニルスルホキシド、フェニルビニル
スルホキシド、ベンジルスルホキシドまたはp−トリル
スルホキシドの存在下、臭化水素酢酸溶液を用いてそれ
ぞれ実施例10と同様に処理すると、いずれも2−(4−
クロロフェニル)−5,6−ジヒドロ−〔1〕ベンゾチエ
ピノ〔5,4−c〕ピリダジン−3(2H)−オンが生成す
ることを、高速液体クロマトグラフィー(HPLC)で確認
した。(保持時間:原料5.4分、生成物9.7分) HPLC条件 装置:LC−6AD(島津) カラム:Shim−pack CLC(島津) 移動相:CH2Cl2、0.4ml/分 検出波長:254nm 実施例16 2−(4−メトキシフェニル)−4,4a,5,6−テトラヒド
ロチエノ〔2,3−h〕シンノリン−3(2H)−オン2.0g
の15%臭化水素−酢酸溶液に室温にてジメチルスルホキ
シド0.45mlを加え、同温にて50分間反応させる。のち、
反応液に水を注ぎ、クロロホルムにて抽出する。水洗
し、硫酸マグネシウムにて乾燥後、減圧濃縮して得られ
る残査をシリカゲルカラムクロマトに付す。クロロホル
ムにて溶出する画分から得られる結晶をクロロホルム−
エタノールの混合溶媒より再結晶すると、融点165〜168
℃の白色結晶として2−(4−メトキシフェニル)−5,
6−ジヒドロチエノ〔2,3−h〕シンノリン−3(2H)−
オン1.0gが得られる。Example 15 2- (4-chlorophenyl) -4,4a, 5,6-tetrahydro- [1] benzothiepino [5,4-c] pyridazine-3 (2
H) -one was treated with hydrobromic acetic acid solution in the presence of diphenyl sulfoxide, phenyl vinyl sulfoxide, benzyl sulfoxide or p-tolyl sulfoxide in the same manner as in Example 10, respectively to give 2- (4-
It was confirmed by high performance liquid chromatography (HPLC) that chlorophenyl) -5,6-dihydro- [1] benzothiepino [5,4-c] pyridazin-3 (2H) -one was produced. (Retention time: 5.4 minutes of raw material, 9.7 minutes of product) HPLC condition Equipment: LC-6AD (Shimadzu) Column: Shim-pack CLC (Shimadzu) Mobile phase: CH 2 Cl 2 , 0.4 ml / min Detection wavelength: 254 nm Example 16 2- (4-Methoxyphenyl) -4,4a, 5,6-tetrahydrothieno [2,3-h] cinnoline-3 (2H) -one 2.0 g
0.45 ml of dimethylsulfoxide is added to the 15% hydrogen bromide-acetic acid solution of (1) at room temperature, and the mixture is reacted at the same temperature for 50 minutes. Later,
Water is poured into the reaction solution and extracted with chloroform. The residue obtained by washing with water, drying over magnesium sulfate and concentration under reduced pressure is subjected to silica gel column chromatography. The crystals obtained from the fraction eluted with chloroform were washed with chloroform-
When recrystallized from a mixed solvent of ethanol, the melting point is 165-168.
2- (4-methoxyphenyl) -5 as white crystals at ℃,
6-dihydrothieno [2,3-h] cinnoline-3 (2H)-
Ong 1.0g is obtained.
上記実施例に従って、次の化合物を合成することができ
る。The following compounds can be synthesized according to the above examples.
◎ 2−(4−クロロフェニル)−10−メチル−2,3,5,
6−テトラヒドロ〔1〕ベンズオキセピノ〔5,4−c〕ピ
リダジン−3−オン、融点172〜173℃ ◎ 10−ブロモ−2−(4−クロロフェニル)2,3,5,6
−テトラヒドロ〔1〕ベンズオキセピノ〔5,4−c〕ピ
リダジン−3−オン、融点214〜216℃ ◎ 2−(4−メトキシフェニル)−2,3,5,6−テトラ
ヒドロ〔1〕ベンズオキセピノ〔5,4−c〕ピリダジン
−3−オン、融点150〜152℃ ◎ 2−フェニル−5,6−ジヒドロベンゾ〔h〕シンノ
リン−3(2H)−オン、融点155〜157℃ ◎ 2−(3−トリフルオロメチルフェニル)−5,6−
ジヒドロベンゾ〔h〕シンノリン−3(2H)−オン、融
点120〜123℃ ◎ 8−クロロ−2−(4−クロロフェニル)−5,6−
ジヒドロベンゾ〔h〕シンノリン−3(2H)−オン、融
点201〜203℃ ◎ 8−クロロ−2−フェニル−5,6−ジヒドロベンゾ
〔h〕シンノリン−3(2H)−オン、融点122〜124℃ ◎ 9−クロロ−2−(4−クロロフェニル)−5,6−
ジヒドロベンゾ〔h〕シンノリン−3(2H)−オン、融
点205〜207℃ ◎ 9−クロロ−2−フェニル−5,6−ジヒドロベンゾ
〔h〕シンノリン−3(2H)−オン、融点184〜186℃ ◎ 9−クロロ−2−(4−ニトロフェニル)−5,6−
ジヒドロベンゾ〔h〕シンノリン−3(2H)−オン、融
点258〜259℃ ◎ 9−クロロ−2−(4−フロオロフェニル)−5,6
−ジヒドロベンゾ〔h〕シンノリン−3(2H)−オン、
融点174〜177℃ ◎ 9−フルオロ−2−フェニル−5,6−ジヒドロベン
ゾ〔h〕シンノリン−3(2H)−オン、融点180〜181℃ ◎ 2−(4−クロロフェニル)−9−フルオロ−5,6
−ジヒドロベンゾ〔h〕シンノリン−3(2H)−オン、
融点176〜179℃ ◎ 9−クロロ−2−(4−メチルフェニル)−5,6−
ジヒドロベンゾ〔h〕シンノリン−3(2H)−オン、融
点184〜186℃ ◎ 2−(4−クロロフェニル)−9−メチル−5,6−
ジヒドロベンゾ〔h〕シンノリン−3(2H)−オン、融
点206〜207℃ ◎ 9−メチル−2−フェニル−5,6−ジヒドロベンゾ
〔h〕シンノリン−3(2H)−オン、融点173〜175℃ ◎ 9−メチル−2−(4−メチルフェニル)−5,6−
ジヒドロベンゾ〔h〕シンノリン−3(2H)−オン、融
点190〜191℃ ◎ 10−クロロ−2−(4−クロロフェニル)−5,6−
ジヒドロ−〔1〕ベンゾチエピノ〔5,4−c〕ピリダジ
ン−3(2H)−オン、融点215〜217℃ ◎ 2−(4−クロロフェニル)−10−フルオロ−5,6
−ジヒドロ−〔1〕ベンゾチエピノ〔5,4−c〕ピリダ
ジン−3(2H)−オン、融点184℃ ◎ 2−(4−ブロモフェニル)−5,6−ジヒドロ−
〔1〕ベンゾチエピノ〔5,4−c〕ピリダジン−3(2
H)−オン、融点208〜209℃ ◎ 2−(4−クロロフェニル)−10−メチル−5,6−
ジヒドロ−〔1〕ベンゾチエピノ〔5,4−c〕ピリダジ
ン−3(2H)−オン・1/2水和物、融点182〜184℃ ◎ 10−フルオロ−2−〔4−フルオロフェニル)−5,
6−ジヒドロ−〔1〕ベンゾチエピノ〔5,4−c〕ピリダ
ジン−3(2H)−オン、融点169〜171℃ ◎ 2−(4−フルオロフェニル)−5,6−ジヒドロ−
〔1〕ベンゾチエピノ〔5,4−c〕ピリダジン−3(2
H)−オン、融点163〜165℃ ◎ 8−クロロ−2−(4−クロロフェニル)−5,6−
ジヒドロ−〔1〕ベンゾチエピノ〔5,4−c〕ピリダジ
ン−3(2H)−オン、融点166〜168℃ ◎ 2−(3,4−ジクロロフェニル)−10−フルオロ−
5,6−ジヒドロ−〔1〕ベンゾチエピノ〔5,4−c〕ピリ
ダジン−3(2H)−オン、融点156〜157℃◎ 2- (4-chlorophenyl) -10-methyl-2,3,5,
6-Tetrahydro [1] benzoxepino [5,4-c] pyridazin-3-one, melting point 172-173 ° C. 10-bromo-2- (4-chlorophenyl) 2,3,5,6
-Tetrahydro [1] benzoxepino [5,4-c] pyridazin-3-one, melting point 214-216 ° C ◎ 2- (4-methoxyphenyl) -2,3,5,6-tetrahydro [1] benzoxepino [5, 4-c] pyridazin-3-one, melting point 150-152 ° C ◎ 2-phenyl-5,6-dihydrobenzo [h] cinnolin-3 (2H) -one, melting point 155-157 ° C ◎ 2- (3-tri Fluoromethylphenyl) -5,6-
Dihydrobenzo [h] cinnoline-3 (2H) -one, melting point 120-123 ° C ◎ 8-chloro-2- (4-chlorophenyl) -5,6-
Dihydrobenzo [h] cinnoline-3 (2H) -one, melting point 201-203 [deg.] ◎ 8-chloro-2-phenyl-5,6-dihydrobenzo [h] cinnoline-3 (2H) -one, melting point 122-124 ° C ◎ 9-chloro-2- (4-chlorophenyl) -5,6-
Dihydrobenzo [h] cinnolin-3 (2H) -one, melting point 205-207 ° C ◎ 9-chloro-2-phenyl-5,6-dihydrobenzo [h] cinnolin-3 (2H) -one, melting point 184-186 ° C ◎ 9-chloro-2- (4-nitrophenyl) -5,6-
Dihydrobenzo [h] cinnoline-3 (2H) -one, melting point 258-259 ° C ◎ 9-chloro-2- (4-fluorophenyl) -5,6
-Dihydrobenzo [h] cinnoline-3 (2H) -one,
Melting point 174-177 ° C ◎ 9-Fluoro-2-phenyl-5,6-dihydrobenzo [h] cinnoline-3 (2H) -one, melting point 180-181 ° C ◎ 2- (4-chlorophenyl) -9-fluoro- 5,6
-Dihydrobenzo [h] cinnoline-3 (2H) -one,
Melting point 176-179 ° C ◎ 9-chloro-2- (4-methylphenyl) -5,6-
Dihydrobenzo [h] cinnoline-3 (2H) -one, melting point 184-186 ° C 2- (4-chlorophenyl) -9-methyl-5,6-
Dihydrobenzo [h] cinnoline-3 (2H) -one, melting point 206-207 [deg.] C. 9-Methyl-2-phenyl-5,6-dihydrobenzo [h] cinnoline-3 (2H) -one, melting point 173-175 ° C ◎ 9-methyl-2- (4-methylphenyl) -5,6-
Dihydrobenzo [h] cinnoline-3 (2H) -one, melting point 190-191 ° C 10-chloro-2- (4-chlorophenyl) -5,6-
Dihydro- [1] benzothiepino [5,4-c] pyridazin-3 (2H) -one, melting point 215-217 ° C 2- (4-chlorophenyl) -10-fluoro-5,6
-Dihydro- [1] benzothiepino [5,4-c] pyridazin-3 (2H) -one, melting point 184 ° C ◎ 2- (4-bromophenyl) -5,6-dihydro-
[1] Benzothieno [5,4-c] pyridazine-3 (2
H) -one, melting point 208-209 ° C. 2- (4-chlorophenyl) -10-methyl-5,6-
Dihydro- [1] benzothiepino [5,4-c] pyridazin-3 (2H) -one hemihydrate, melting point 182-184 ° C ◎ 10-fluoro-2- [4-fluorophenyl) -5,
6-Dihydro- [1] benzothiepino [5,4-c] pyridazin-3 (2H) -one, melting point 169-171 ° C ◎ 2- (4-fluorophenyl) -5,6-dihydro-
[1] Benzothieno [5,4-c] pyridazine-3 (2
H) -one, melting point 163-165 ° C. ◎ 8-chloro-2- (4-chlorophenyl) -5,6-
Dihydro- [1] benzothiepino [5,4-c] pyridazin-3 (2H) -one, melting point 166-168 ° C ◎ 2- (3,4-dichlorophenyl) -10-fluoro-
5,6-Dihydro- [1] benzothiepino [5,4-c] pyridazin-3 (2H) -one, melting point 156-157 ° C
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 庁内整理番号 FI 技術表示箇所 C07D 495/04 111 116 495/14 F Z ─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 6 Identification code Internal reference number FI technical display location C07D 495/04 111 111 116 495/14 FZ
Claims (3)
2は同一または異なって水素、ハロゲン、トリフルオロ
メチル、ヒドロキシ、アミノ、ニトロ、シアノ、低級ア
ルキル、低級アルコキシまたは低級アルカノイルアミノ
を、R3は水素、炭素数1〜8個を有するアルキル、ヒド
ロキシアルキル、アルカノイルオキシアルキル、アリー
ル、アラルキル、ヘテロアリールまたは芳香環上にハロ
ゲン、ヒドロキシ、アミノ、ニトロ、シアノ、低級アル
キル、低級アルコキシ、低級アルカノイルアミノ、ハロ
アルキル、アシルオキシ、低級アルコキシカルボニルお
よびカルボキシから選ばれる置換基を少なくとも1個有
しているアリール、アラルキルもしくはヘテロアリール
を、XはO,S,SO,SO2,CH2またはNR4(R4は水素、低級ア
ルキル、アシルまたはベンゼンスルホニルを示す。)
を、nは1または2を示す。〕 により表わされる化合物を、必要によりスルホキシド化
合物の存在下、酸と反応させることを特徴とする一般式 (式中、各記号は前記と同義である。) により表わされるピリダジノン化合物の製造法。1. A general formula Wherein ring A benzene ring or thiophene ring, R 1, R
2 is the same or different and is hydrogen, halogen, trifluoromethyl, hydroxy, amino, nitro, cyano, lower alkyl, lower alkoxy or lower alkanoylamino, R 3 is hydrogen, alkyl having 1 to 8 carbons, hydroxyalkyl A substituent selected from halogen, hydroxy, amino, nitro, cyano, lower alkyl, lower alkoxy, lower alkanoylamino, haloalkyl, acyloxy, lower alkoxycarbonyl and carboxy on the alkanoyloxyalkyl, aryl, aralkyl, heteroaryl or aromatic ring. An aryl, aralkyl or heteroaryl having at least one of, X is O, S, SO, SO 2 , CH 2 or NR 4 (R 4 represents hydrogen, lower alkyl, acyl or benzenesulfonyl).
And n represents 1 or 2. ] The compound represented by the formula is reacted with an acid in the presence of a sulfoxide compound, if necessary. (In the formula, each symbol has the same meaning as defined above.) A method for producing a pyridazinone compound represented by
フェニルスルホキシド、フェニルビニルスルホキシド、
ジベンジルスルホキシド、p−トリルスルホキシド、メ
チルフェニルスルホキシドまたはレゾルシノールスルホ
キシドであり、酸が臭化水素酸、塩酸、ヨウ化水素酸の
ハロゲン化水素酸、メタンスルホン酸、トリフルオロメ
タンスルホン酸のアルキルスルホン酸、酢酸、ギ酸、ト
リフルオロ酢酸の脂肪族カルボン酸、p−トルエンスル
ホン酸のアリールスルホン酸、またはその混合物である
ことを特徴とする請求項1記載の製造法。2. A sulfoxide is dimethyl sulfoxide, diphenyl sulfoxide, phenyl vinyl sulfoxide,
Dibenzyl sulfoxide, p-tolyl sulfoxide, methylphenyl sulfoxide or resorcinol sulfoxide, wherein the acid is hydrobromic acid, hydrochloric acid, hydrohalic acid of hydroiodic acid, methanesulfonic acid, alkylsulfonic acid of trifluoromethanesulfonic acid, The production method according to claim 1, which is an aliphatic carboxylic acid such as acetic acid, formic acid, or trifluoroacetic acid, an arylsulfonic acid such as p-toluenesulfonic acid, or a mixture thereof.
フェニルスルホキシド、フェニルビニルスルホキシド、
ジベンジルスルホキシドまたはp−トリルスルホキシド
であり、酸がメタンスルホン酸、酢酸またはトリフルオ
ロ酢酸であることを特徴とする請求項1記載の製造法。3. A sulfoxide is dimethyl sulfoxide, diphenyl sulfoxide, phenyl vinyl sulfoxide,
The method according to claim 1, wherein the method is dibenzyl sulfoxide or p-tolyl sulfoxide, and the acid is methanesulfonic acid, acetic acid or trifluoroacetic acid.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2147087A JPH0730035B2 (en) | 1990-06-05 | 1990-06-05 | Process for producing pyridazinone compound |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2147087A JPH0730035B2 (en) | 1990-06-05 | 1990-06-05 | Process for producing pyridazinone compound |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH0441482A JPH0441482A (en) | 1992-02-12 |
JPH0730035B2 true JPH0730035B2 (en) | 1995-04-05 |
Family
ID=15422176
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2147087A Expired - Lifetime JPH0730035B2 (en) | 1990-06-05 | 1990-06-05 | Process for producing pyridazinone compound |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0730035B2 (en) |
-
1990
- 1990-06-05 JP JP2147087A patent/JPH0730035B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JPH0441482A (en) | 1992-02-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69936998T2 (en) | PYRAZOLOTRIAZINE DERIVATIVES AS GABA RECEPTOR LIGANDS | |
WO2002036599A1 (en) | Thieno[2,3-c]isoquinolines for use as inhibitors of parp | |
EP2066672B1 (en) | An improved process for the preparation of temozolomide and analogs | |
SU568366A3 (en) | Process for preparing benzodiazepine derivatives and 5-oxides or salts thereof | |
JPH035481A (en) | Pyridazinone derivative | |
US4684658A (en) | Anti-thrombotic ortho-condensed pyrrole derivatives, compositions, and method of use therefor | |
JPS6089469A (en) | Spiro tricyclic aromatic succinimide derivative as aldose reductase inhibitor, treatment thereby and drug composition | |
JPH0417198B2 (en) | ||
JPH0240067B2 (en) | ||
PL97275B1 (en) | METHOD OF MAKING NEW DERIVATIVES OF THENOTRIIAZOLODUAZEPINE | |
JPH0730035B2 (en) | Process for producing pyridazinone compound | |
EP0000301B1 (en) | Process for the preparation of thieno(2,3-c) and thieno(3,2-c) pyridines | |
GB2055825A (en) | Process for producing 7-alkoxycarbonyl-6,8-dimethyl-4-hydroxymethyl-1-phthalazone | |
US4201712A (en) | Process for preparation of 6-aryl-4H-s-triazolo-[3,4-c]-thieno-[2,3-e]-1,4-diazepines | |
Sasaki et al. | The synthesis of novel polycyclic heterocyclic ring systems via photocyclization. 7.[1] Benzothieno [2, 3‐c] naphtho [2, 1‐h] quinoline and [1] benzothieno [2, 3‐c] naphtho [2, 1‐h][1, 2, 4] triazolo [4, 3‐a] quinoline | |
Ning et al. | Carbon-nitrogen vs nitrogen-nitrogen bond formation in nitrenoid cyclization reactions. Pyrolysis of 3-azido-4-(2-pyridyl) carbostyrils | |
JPH0365349B2 (en) | ||
EP0892804B1 (en) | Isoxazolidine derivatives | |
Ferreira et al. | Synthesis of new methylated thieno [2, 3‐a] and [3, 2‐b] carbazoles by reductive cyclization of 6‐(2′‐Nitrophenyl) benzo [b] thiophenes obtained by palladium‐catalyzed cross‐coupling isabel | |
JPH0633277B2 (en) | Benzothiopyrano [4,3-C] pyridazine compound | |
GB2096143A (en) | Imidazo(1,2-a)quinoline derivatives | |
JPH03279386A (en) | Thiophene compound, medical use and intermediate thereof | |
CS214806B2 (en) | Method of making the derivatives of the auron | |
CA1327572C (en) | Imidazodiazepine derivatives | |
PL91799B1 (en) |